Internal Medicine, Rheumatology · Fort Collins, CO
NPI
1629045364
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
2121 E Harmony Rd, Ste 361
Fort Collins, CO, 80528
Phone (970) 267-9799
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.1M
159,362 services
Medicare patients, 2024
984
Average age 73
Drug cost, 2024
$3.2M
5,315 prescriptions
Company payments, 2025
$35
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael S Thakor was code J3262 (injection, tocilizumab, 1 mg), 54,600 times for 17 patients. In total Michael S Thakor billed 159,362 services in 36 codes, and Medicare paid $2.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-04-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 54,600 | 17 | $4.69 | $256K |
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 48,800 | 14 | $3.59 | $175K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 17,171 | 60 | $24.65 | $423K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 14,725 | 26 | $33.80 | $498K |
| J0897 Injection, denosumab, 1 mg | Office | 4,860 | 46 | $20.34 | $99K |
| J9312 Injection, rituximab, 10 mg | Office | 3,700 | 14 | $61.20 | $226K |
| 99213 Office E&M - Established | Office | 1,685 | 816 | $63.56 | $107K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 813 | 13 | $0.23 | $185 |
| 96413 Chemotherapy Administration | Office | 558 | 95 | $105.11 | $59K |
| 96415 Chemotherapy Administration | Office | 485 | 75 | $22.33 | $11K |
| 99214 Office E&M - Established | Office | 352 | 246 | $93.89 | $33K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 317 | 45 | $0.69 | $219 |
| 96401 Chemotherapy Administration | Office | 248 | 14 | $58.41 | $14K |
| 96365 Intravenous Infusion, Hydration | Office | 229 | 38 | $50.75 | $12K |
| 99204 Office E&M - New | Office | 159 | 159 | $108.68 | $17K |
By year: 2022 $2.0M for 111,887 services; 2023 $2.2M for 148,899 services; 2024 $2.1M for 159,362 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael S Thakor prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 783 prescriptions and refills. In total Michael S Thakor wrote 5,315 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 783 | 1,555 | 180 | $19K |
| Prednisone Generic | 699 | 1,125 | 180 | $5,493 |
| Hydroxychloroquine Sulfate Generic | 681 | 1,467 | 171 | $26K |
| Celecoxib Generic | 215 | 395 | 50 | $6,849 |
| Meloxicam Generic | 212 | 480 | 71 | $967 |
| Leflunomide Generic | 182 | 349 | 50 | $9,253 |
| Sulfasalazine Generic | 158 | 292 | 37 | $3,890 |
| Gabapentin Generic | 149 | 305 | 35 | $2,718 |
| Tramadol Hcl Generic | 125 | 125 | 30 | $895 |
| Duloxetine Hcl Generic | 121 | 260 | 28 | $2,885 |
| Allopurinol Generic | 107 | 285 | 28 | $923 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 102 | 102 | 17 | $2,576 |
| Enbrel Sureclick Etanercept | 96 | 114 | 12 | $869K |
| Alendronate Sodium Generic | 90 | 185 | 22 | $559 |
| Nabumetone Generic | 85 | 150 | 18 | $1,479 |
Brand drugs: 792 claims; generic drugs: 4,510 claims; opioid claims: 285.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael S Thakor $35 ($35 in general payments such as food, travel and fees) from 8 companies. The largest payer was Merck Sharp & Dohme LLC with $35.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 1 | $35 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.